In a study whose findings have not yet been published, he and a colleague, Daniel Friedman, found that patients receiving CBD in addition to their usual medicines had 39 percent fewer convulsive seizures than patients who remained on their normal drug regimen. Given that the study included only the most treatment-resistant patients, this is an “excellent response,” Devinsky says.
Third party laboratories analyze all of our full-spectrum hemp extracts and supplements for cannabinoid potency, heavy metals, bacterial/microbial life, mycotoxins (fungus), and pesticides. Our isolate is tested for potency, heavy metals, and pesticides. The unsummarized results of testing for all produced batches can be found in our online batch database.

CBD Topical

×